Alexis Retractor in Total Hip Arthroplasty
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Miami
About this trial
To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.
Eligibility criteria
Qualifiers
Patients undergoing primary unilateral longitudinal direct anterior approach total hip arthroplasty
Patients undergoing primary total hip arthroplasty
Disqualifiers
Patients with history of prior open surgery on the affected hip
Patients with history of prior total hip arthroplasty on the contralateral hip
Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement
Trial design
Treatments tested in this trial
- Alexis wound retractor
- Standard wound retractor
Treatment groups
202 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov